Hepatocellular carcinoma surveillance in primary care
J. Lubel , A. Nicoll , S. Sood , I. Kronborg
Journal of Gastroenterology and Hepatology 31
2016
Advances in chemotherapeutics for the treatment of periodontal diseases
Lorne M. Golub , Mark Wolff , G.S. Payonk , M. Leung
Journal of the American Dental Association 163 -169
1994
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir, with or without ribavirin, in adults treated with the regimen approved in Australia, Canada, New Zealand, and Switzerland
T. Podsadecki , J. F. Dufour , S. I. Strasser , J. Feld
Journal of Gastroenterology and Hepatology 31 71 -72
2016
6 SUBANALYSES OF THE TELAPREVIR LEAD-IN ARM IN THE REALIZE STUDY: RESPONSE AT WEEK 4 IS NOT A SUBSTITUTE FOR PRIOR NULL RESPONSE CATEGORIZATION
G.R. Foster , S. Zeuzem , P. Andreone , S. Pol
Journal of Hepatology 54
25
2011
13 SIMILAR SVR RATES IN IL28B CC, CT OR TT PRIOR RELAPSER PARTIAL- OR NULL-RESPONDER PATIENTS TREATED WITH TELAPREVIR/PEGINTERFERON/RIBAVIRIN: RETROSPECTIVE ANALYSIS OF THE REALIZE STUDY
S. Pol , J. Aerssens , S. Zeuzem , P. Andreone
Journal of Hepatology 54
65
2011
749 EARLY ON-TREATMENT RESPONSES DURING PEGYLATED IFN PLUS RIBAVIRIN ARE INCREASED FOLLOWING 13 DAYS OF COMBINATION NUCLEOSIDE POLYMERASE (RG7128) AND PROTEASE (RG7227) INHIBITOR THERAPY (INFORM-1)
E. Gane , S. Roberts , C. Stedman , P. Angus
Journal of Hepatology 52
8
2010
Relation of Liver Stiffness to Heart Failure and Associated Volume Overload
H. Krum , P. Porapakkham , P. Porapakkham , S. Casey
Heart Lung and Circulation 19
2010
Efficacy and safety of calcineurin inhibitors as salvage therapy in patients with autoimmune hepatitis
S. Strasser , R. Lim , J. Mitchell , A. Nicoll
Journal of Hepatology 68
2018
Preliminary analysis of the Prime Study; A randomized controlled trial comparing the hepatitis C care cascade in primary care vs. tertiary care
A. Wade , J. Doyle , E. Gane , C. Stedman
Journal of Hepatology 68
1
2018
Upright positive expiratory pressure therapy and exercise: effects on gastroesophageal reflux in COPD and bronchiectasis.
A. L. Lee , L. Denehy , J. W. Wilson , S. Roberts
Respiratory Care 57 ( 9) 1460 -1467
8
2012
Exhaled Breath Condensate Pepsin: Potential Noninvasive Test for Gastroesophageal Reflux in COPD and Bronchiectasis.
A. L. Lee , B. M. Button , L. Denehy , S. Roberts
Respiratory Care 60 ( 2) 244 -250
26
2015
Epidemiology of hepatitis B-associated hepatocellular carcinoma in Victoria
M. Sinclair , S. Roberts , W. Kemp , V. Knight
Internal Medicine Journal 43 ( 5) 501 -506
7
2013
SUN-LB311: FTO RS9939609 Polymorphism in non Alcoholic Fatty Liver Disease – Frequency and Characteristics of Risk Genotypes
A.C. Tierney , E. George , A. Reddy , M. Ryan
Clinical Nutrition 36
2017
1420 THE EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF BI201335 AND BI207127 IN GENOTYPE 1 HCV PATIENTS WITH CIRRHOSIS - INTERIM ANALYSIS FROM SOUND-C2
V. Soriano , E. Gane , P. Angus , F. Stickel
Journal of Hepatology 56 S559
15
2012
253 COMPARISON OF SURVIVAL OUTCOMES BETWEEN PATIENTS WITH VIRAL AND NON-VIRAL RELATED HEPATOCELLULAR CARCINOMA: A LARGE MULTI-CENTRE STUDY
B. Christensen , S. Bell , P. Gow , M. Fink
Journal of Hepatology 58
2013
P427 POTENTIAL IMPACT OF IMPROVED TREATMENT ON DISEASE BURDEN OF CHRONIC HEPATITIS C IN AUSTRALIA
G.J. Dore , H. Razavi , C. Estes , A. Thompson
Journal of Hepatology 60 ( 1)
2014
Influence of hepatic dysfunction on safety, tolerability, and pharmacokinetics (PK) of PTK787/ZK 222584 in patients (Pts) with unresectable hepatocellular carcinoma (HCC)
I. Koch , A. Baron , S. Roberts , U. Junker
Journal of Clinical Oncology 23 ( 16_suppl) 4134 -4134
35
2005
OP03 Telaprevir-based therapy in G1 HCV-infected patients with prior null response, partial response or relapse to peginterferon/ribavirin: REALIZE trial final results
G. Foster , S. Zeuzem , P. Andreone , S. Pol
Gut 60
6
2011
Guidelines for the prevention of sepsis in asplenic and hyposplenic patients.
D. Spelman , J Buttery , A. Daley , D. Isaacs
Internal Medicine Journal 38 ( 5) 349 -356
62
2008
Transjugular liver biopsy is a safe and effective intervention to guide management for patients with a congenital bleeding disorder infected with hepatitis C
M. A. Dawson , P. H. McCarthy , M. E. Walsh , C. A. McLean
Internal Medicine Journal 35 ( 9) 556 -559
14
2005